Ergi3/Ergic-3 anticorps (HRP)

Détails pour le produit réf. ABIN1712258, Fournisseur: Connectez-vous pour afficher
Antigène
Reactivité
Humain, Souris, Rat (Rattus)
14
14
14
Hôte
Lapin
14
Clonalité
Polyclonal
Conjugué
HRP
1
1
1
1
1
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
13
2
2
Options
Fournisseur
Connectez-vous pour afficher
Supplier Product No.
Connectez-vous pour afficher
Request

Ce produit gratuit

Envoyez-nous votre proposition de validation. J'aimerais valider ce produit

Savoir plus

Immunogène KLH conjugated synthetic peptide derived from human ERGI3/ERGIC-3
Isotype IgG
Purification Purified by Protein A.
Sujet

Cycling proteins play important roles in the organization and function of the early secretory pathway by participating in membrane traffic and selective transport of cargo between the endoplasmic reticulum (ER), the intermediate compartment (ERGIC), and the Golgi. A family of membrane bound, ubiquitous proteins involved in the selective transport of newly synthesized glycoproteins from the ER to the ERGIC include VIP36, ERGIC-53, ERGIC-1, ERGIC-2 and ERGIC-3. ERGIC-1, also designated ERGIC32, is thought to modulate the activity of a complex formed by ERGIC-2, also designated Erv41, and ERGIC-3, also designated Erv46. ERGIC-2 and ERGIC-3 are both mammalian homologs of yeast proteins abundant in COPII-coated vesicles and localize to the Cis-face of the Golgi apparatus.

Synonyms: 2310015B14Rik, AV318804, C20orf47, CGI 54, D2Ucla1, dJ477O4.2, DKFZp547A2190, Endoplasmic reticulum Golgi intermediate compartment protein 3, endoplasmic reticulum localized protein ERp43, Endoplasmic reticulum-Golgi intermediate compartment protein 3, ERGI3_HUMAN, ERGIC and golgi 3, ergic3, ERV46, NY BR 84, PRO0989, RP23-220D12.2, RP3-477O4.1, SDBCAG84, serologically defined breast cancer antigen 84, Serologically defined breast cancer antigen NY BR 84, Serologically defined breast cancer antigen NY-BR-84.

ID gène 51614
Indications d'application WB 1:100-1000
IHC-P 1:100-500
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % Gentamicin.
Agent conservateur Gentamicin sulfate
Précaution d'utilisation This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
Stock 4 °C
Stockage commentaire Store at 4°C
Date de péremption 12 months